Sign in
4

Changes in Ownership

Protagenic Therapeutics, Inc.new Filed Acc 0001493152-21-013384

Options or other derivatives

  • Director acquired 180,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Barrage Khalil Director 2021-05-26 Grant or award · PTIX Common stock NSO Options +180,000 180,000 D
Loading xslF345X03/ownership.xml…